Company: CERO
Filing Date: 2025-11-17
Form Type: PRE 14A
Source: 0001213900-25-111175
Chunk: 37

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-17
Form: PRE 14A
Chunk 37
---
ives, including: •Anticipated equity awards to be granted in connection with the engagement of a new permanent CEO and growth anticipated as CER -1236advances to clinical development; •The fact that, in light of the status of the Company’s development and need to fund clinical trials following acceptance of the IND, it expects to conduct additional financing transactions through the remainder of 2025 and throughout 2026, which can be expected to increase the number of fully diluted shares outstanding and reduce the percentage of the fully diluted shares outstanding constituted by the pool. In order to have sufficient shares available for grants that are competitive in attracting new talent, the Company will need a pool sufficiently large to constitute a significant percentage of the fully diluted shares outstanding after completing such financing; •Certain equity awards granted to executives in 2024 and 2025 are subject to acceleration for the achievement of goals relating to the Company’s clinical development; and •Executive equity is heavily weighted to instruments that require strong performance thereby incentivizing the delivery of value. 20 The Company expects that the shares requested under the Amended Plan will provide for grants to Company personnel for the remainder of 2025 and will be augmented by the annual evergreen provision in January 1, 2026 as described in the 2024 Plan. Description of the Amended Plan A summary description of the material features of the Amended Plan is set forth below. The following summary does not purport to be a complete description of all the provisions of the Amended Plan and is qualified by reference to the Plan, as proposed to be amended by the Amendment. Stockholders should refer to the Amended Plan for more complete and detailed information about the terms and conditions of the Amended Plan. Eligibility.Any individual who is an employee of the Company or any of its affiliates, or any person who provides services to the Company or its affiliates, including members of the Board, is eligible to receive awards under the Amended Plan at the discretion of the plan administrator. As of the Record Date, there were 27 employees, non -employeedirectors and consultants eligible to receive awards under the Amended Plan. Awards.The Amended Plan provides for the grant of incentive stock options (“ISOs”), within the meaning of Section 422 of the Code to employees, including employees of any parent or subsidiary, and for the grant of nonstatutory stock options (“NSOs”), stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards and other forms of awards to employees, directors and consultants